Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL49035 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL7525209 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL11659 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL18260580 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL2902509 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL2837841 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL7921264 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL19974227 | 0.94 | SLC34A1 (0.50) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL22263534 | 0.94 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL22263543 | 0.94 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116926971-B | Antigen fibrillation composition and application thereof in lyocell fabric | 广东德美精细化工集团股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-114951252-B | Super-capacitor type soil heavy metal ion in-situ removal method and device | 长沙稷下科技咨询有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117090052-A | Preparation method of antigen fibrillated lyocell fibers | 广东德美精细化工集团股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116926971-A | Antigen fibrillation composition and application thereof in lyocell fabric | 广东德美精细化工集团股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-108586769-A | A kind of fluorescence dissaving polymer modified collagen protein material and preparation method thereof | 烟台大学 | 2018-09-28 | — | — | CN | claimed |
| CN-106546668-A | A kind of HPLC methods for separating good fortune department's fluconazole or its pharmaceutical salts about material | 陕西合成药业股份有限公司 | 2017-03-29 | — | — | CN | claimed |
| EP-0760106-B1 | METHOD OF INCREASING THE CONCENTRATION OF RADIATION-ABSORBING AGENTS IN OPTICAL AND OPHTHALMIC LENSES | NOVARTIS AG (CH) | 1999-07-07 | — | — | EP | claimed |
| EP-0760106-A1 | METHOD OF INCREASING THE CONCENTRATION OF RADIATION-ABSORBING AGENTS IN OPTICAL AND OPHTHALMIC LENSES | Novartis AG (CH) | 1997-03-05 | — | — | EP | claimed |
| US-5480927-A | Method of increasing the concentration of radiation-absorbing agents in optical and ophthalmic lenses | CIBA GEIGY CORPORATION (US) | 1996-01-02 | — | — | US | claimed |
| WO-1995032440-A1 | METHOD OF INCREASING THE CONCENTRATION OF RADIATION-ABSORBING AGENTS IN OPTICAL AND OPHTHALMIC LENSES | CIBA-GEIGY AG (CH) | 1995-11-30 | — | — | WO | claimed |
| US-20260124128-A1 | COMPOSITION COMPRISING LARGE AMOUNT OF POLYOL | L'OREAL (FR) | 2026-05-07 | — | — | US | disclosed |
| US-12605324-B2 | Composition comprising ingredients for DIC-gel and polyol | L'OREAL (FR) | 2026-04-21 | — | — | US | disclosed |
| US-12453691-B2 | Composition comprising hyaluronic acid-based polyion complex particle | L'OREAL (FR) | 2025-10-28 | — | — | US | disclosed |
| EP-4598499-A1 | COSMETIC COMPOSITION FOR A MATTE FOUNDATION | L'OREAL (FR) | 2025-08-13 | — | — | EP | disclosed |
| EP-4580586-A1 | COSMETIC WATER IN OIL COMPOSITION COMPRISING POLYVINYLPYRROLIDONE AS THICKENER | L'OREAL (FR) | 2025-07-09 | — | — | EP | disclosed |
| US-20050187135-A1 | Process for producing a refined product of polyoxyproylene fatty acid isopropanolamide surfactant | KAWAKEN FINE CHEMICALS CO., LTD. (JP) | 2005-08-25 | — | — | US | disclosed |
| US-20030176311-A1 | Purified polyoxypropylene fatty acid isopropanolamide surfactants, production thereof and detergent compositions containing the surfactants | KAWAKEN FINE CHEMICALS CO., LTD. (JP) | 2003-09-18 | — | — | US | disclosed |
| EP-1298123-A1 | PURIFIED POLYOXYPROPYLENE FATTY ACID ISOPROPANOLAMIDE SURFACTANTS, PRODUCTION THEREOF AND DETERGENT COMPOSITIONS CONTAINING THE SURFACTANTS | Kawaken Fine Chemicals Co., Ltd. (JP) | 2003-04-02 | — | — | EP | disclosed |
| US-5480927-A | Method of increasing the concentration of radiation-absorbing agents in optical and ophthalmic lenses | CIBA GEIGY CORPORATION (US) | 1996-01-02 | — | — | US | disclosed |
| EP-0621284-A1 | PEPTIDES CONTAINING RESPECTIVE AMINO ACID SEQUENCES SELECTED FROM AMONG THOSE OF LIPOPROTEIN(a) AND APOLIPOPROTEIN(a), ANTIBODIES RESPECTIVELY RECOGNIZING THESE AMINO ACID SEQUENCES, AND METHOD OF ASSAYING WITH THESE ANTIBODIES | SHINO-TEST CORPORATION (JP) | 1994-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605324-B2 | Composition comprising ingredients for DIC-gel and polyol | ALG1, DAD1, DDOST | LMNA 981/4885SLC34A1 1663/4885KDM4E 3428/4885 |
| US-20260124128-A1 | COMPOSITION COMPRISING LARGE AMOUNT OF POLYOL | GK, PRKG2, PRKG1 | LMNA 1411/4885SLC34A1 2995/4885KDM4E 3156/4885 |
| US-12453691-B2 | Composition comprising hyaluronic acid-based polyion complex particle | CD44, PRKCA, H1-0 | LMNA 2659/4885SLC34A1 434/4885KDM4E 4101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.